Vertex to Announce First-Quarter 2019 Financial Results on April 30
April 12 2019 - 8:00AM
Business Wire
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) will report
its first quarter 2019 financial results on Tuesday, April 30, 2019
after the financial markets close. The company will host a
conference call and webcast at 4:30 p.m. ET. To access the call,
please dial (866) 501-1537 (U.S.) or +1 (720) 545-0001
(International).
The conference call will be webcast live and a link to the
webcast can be accessed through Vertex's website at www.vrtx.com in
the "Investors" section. To ensure a timely connection, it is
recommended that participants register at least 15 minutes prior to
the scheduled webcast. An archived webcast will be available on the
company's website.
About Vertex
Vertex is a global biotechnology company that invests in
scientific innovation to create transformative medicines for people
with serious and life-threatening diseases. In addition to clinical
development programs in CF, Vertex has more than a dozen ongoing
research programs focused on the underlying mechanisms of other
serious diseases.
Founded in 1989 in Cambridge, Mass., Vertex's headquarters is
now located in Boston’s Innovation District. Today, the company has
research and development sites and commercial offices in the United
States, Europe, Canada, Australia and Latin America. Vertex is
consistently recognized as one of the industry's top places to
work, including being named to Science magazine's Top Employers in
the life sciences ranking for nine years in a row.
For additional information and the latest updates from the
company, please visit www.vrtx.com.
(VRTX-WEB)
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190412005070/en/
Vertex Pharmaceuticals Incorporated
Investors:Michael Partridge, 617-341-6108Eric Rojas,
617-961-7205Zach Barber, 617-341-6470
Vertex Pharmaceuticals (NASDAQ:VRTX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Vertex Pharmaceuticals (NASDAQ:VRTX)
Historical Stock Chart
From Apr 2023 to Apr 2024